Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Daniel Horber"'
1
Akademický článek
Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes.
Autor: Katharina Burmeister, Luca Quagliata, Mariacarla Andreozzi, Serenella Eppenberger-Castori, Matthias S Matter, Valeria Perrina, Rainer Grobholz, Wolfram Jochum, Daniel Horber, Peter Moosmann, Frank Lehmann, Dieter Köberle, Charlotte K Y Ng, Salvatore Piscuoglio, Luigi Tornillo, Luigi M Terracciano
Publikováno v: PLoS ONE, Vol 12, Iss 4, p e0175563 (2017)
VEGFA is an angiogenic factor secreted by tumors, in particular those with VEGFA amplification, as well as by macrophages and lymphocytes in the tumor microenvironment. Here we sought to define the presence of M1/M2 macrophages, PD-1-positive lymphoc
Externí odkaz: https://doaj.org/article/c6d2a8a320584496ab6344e75b74821f
Zobrazit plný text záznamu
2
Choice of first line systemic treatment in pancreatic cancer among national experts
Autor: M. Montemurro, Ralph Winterhalder, Martin D. Berger, M. Glatzer, Bernhard C. Pestalozzi, Miklos Pless, P.M. Putora, S. Pederiva, Daniel Horber, R. Inauen
Publikováno v: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 20(4)
BACKGROUND Treatment options for patients with metastatic pancreatic cancer depend on various factors, including performance status, tumor burden and patient preferences. Metastatic pancreatic cancer is incurable and many systemic treatment options h
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6249e7c7c8951502dec60606b473d996
https://pubmed.ncbi.nlm.nih.gov/32299764
Zobrazit plný text záznamu
4
Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes
Autor: Valeria Perrina, Matthias S. Matter, Serenella Eppenberger-Castori, Luca Quagliata, Dieter Köberle, Wolfram Jochum, Peter Moosmann, Rainer Grobholz, Mariacarla Andreozzi, Frank Serge Lehmann, Luigi Terracciano, Salvatore Piscuoglio, Daniel Horber, Luigi Tornillo, Katharina Burmeister, Charlotte K.Y. Ng
Publikováno v: PLoS ONE, Vol 12, Iss 4, p e0175563 (2017)
PLoS ONE
VEGFA is an angiogenic factor secreted by tumors, in particular those with VEGFA amplification, as well as by macrophages and lymphocytes in the tumor microenvironment. Here we sought to define the presence of M1/M2 macrophages, PD-1-positive lymphoc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfc876a2586e411cc8cc9ac4b0f976b1
https://edoc.unibas.ch/68140/
Zobrazit plný text záznamu
5
Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients
Autor: Jürgen Fornaro, Joachim Müller, Meinhard Knitel, Martin Fehr, Thomas Cerny, Dieter Koeberle, Ulrich Güller, Daniel Horber
Publikováno v: Clinical colorectal cancer. 16(4)
Introduction Clinical practice guidelines regarding follow-up in patients after curative resection of colorectal cancer (CRC) vary widely. Current follow-up recommendations do not include additional postoperative imaging before starting adjuvant trea
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9c2e4cda2dbb1b6d0b976be906c2da2
https://pubmed.ncbi.nlm.nih.gov/28412138
Zobrazit plný text záznamu
8
Relative survival is an adequate estimate of cancer-specific survival: baseline mortality-adjusted 10-year survival of 771 rectal cancer patients
Autor: Daniel Horber, Alexis Ulrich, Thomas Cerny, Ulrich Güller, Philipp Achermann, Rene Warschkow, Zeno Stanga, Ignazio Tarantino, Bruno M. Schmied
Publikováno v: Tarantino, Ignazio; Achermann, Philipp; Güller, Ulrich; Ulrich, Alexis; Schmied, Bruno M; Horber, Daniel; Cerny, Thomas; Stanga, Zeno; Warschkow, Rene (2013). Relative survival is an adequate estimate of cancer-specific survival: baseline mortality-adjusted 10-year survival of 771 rectal cancer patients. Annals of surgical oncology, 20(12), pp. 3877-3884. Springer 10.1245/s10434-013-3173-5
BACKGROUND The objective of the present investigation is to assess the baseline mortality-adjusted 10-year survival of rectal cancer patients. METHODS Ten-year survival was analyzed in 771 consecutive American Joint Committee on Cancer (AJCC) stage I
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bedb51c4d4345fcb233f21b9c0d8e1df
https://boris.unibe.ch/54000/1/art_10.1245_s10434-013-3173-5.pdf
Zobrazit plný text záznamu
9
Health Economic Analysis of the Randomized Multicenter Phase Ii Trial Sakk 77/08: Sorafenib with or Without Everolimus in Patients with Unresectable Hepatocellular Carcinoma (Hcc)
Autor: Piercarlo Saletti, Matthias Schwenkglenks, B. Tschanz, Dieter Koeberle, A. Roth, Qiyu Li, Klazien Matter-Walstra, I. Cvijetic, Panagiotis Samaras, Daniel Horber
Publikováno v: Annals of Oncology. 25:iv358
Aim: Sorafenib (S), a multitargeted tyrosine kinase inhibitor, has become standard of care for first-line systemic treatment of advanced HCC. Everolimus (E) is a potent inhibitor of the mTOR. In preclinical HCC-models, S + E has additive effects comp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3e6b402bef1e70114f5836c3918ea38f
https://doi.org/10.1093/annonc/mdu341.3
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje